Titan Pharmaceuticals, Inc.
TTNP
$4.40
-$0.05-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.95M | 2.83M | 3.40M | 4.09M | 6.16M |
| Total Receivables | 81.00K | 62.00K | 52.00K | 38.00K | 134.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 130.00K | 30.00K | 151.00K | 220.00K | 318.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.16M | 2.92M | 3.60M | 4.35M | 6.61M |
|
|
|||||
| Total Current Assets | 2.16M | 2.92M | 3.60M | 4.35M | 6.61M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 35.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.16M | 2.92M | 3.60M | 4.35M | 6.65M |
|
|
|||||
| Total Accounts Payable | 194.00K | 202.00K | 371.00K | 356.00K | 371.00K |
| Total Accrued Expenses | 85.00K | 281.00K | -- | -- | 155.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 33.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 279.00K | 483.00K | 371.00K | 356.00K | 559.00K |
|
|
|||||
| Total Current Liabilities | 279.00K | 483.00K | 371.00K | 356.00K | 559.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 279.00K | 483.00K | 371.00K | 356.00K | 559.00K |
|
|
|||||
| Common Stock & APIC | 398.98M | 398.98M | 398.98M | 398.98M | 398.98M |
| Retained Earnings | -397.10M | -396.54M | -395.75M | -394.98M | -392.89M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.88M | 2.44M | 3.23M | 3.99M | 6.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | 1.00K | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | 1.88M | 2.44M | 3.23M | 3.99M | 6.09M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.88M | 2.44M | 3.23M | 3.99M | 6.09M |
|
|
|||||